CHIPPING CAMPDEN SURGERY
BACK ENDS, CHIPPING CAMPDEN
STIA007
The percentage of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record in the preceding 12 months that an anti-platelet agent, or an anti-coagulant is being taken
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| STROKE 9 | 2005 | 61 | 61 | 100.0% | |
| STROKE 9 | 2006 | 73 | 76 | 96.1% | |
| Stroke 12 | 2007 | 88 | 91 | 96.7% | |
| Stroke 12 | 2008 | 83 | 86 | 96.5% | |
| Stroke 12 | 2009 | 93 | 99 | 93.9% | |
| Stroke 12 | 2010 | 94 | 100 | 94.0% | |
| STROKE 12 | 2011 | 103 | 112 | 92.0% | |
| STROKE 12 | 2012 | 105 | 113 | 92.9% | |
| STROKE 12 | 2013 | 98 | 104 | 94.2% | |
| STIA007 | 2014 | 108 | 114 | 94.7% | |
| STIA007 | 2015 | 116 | 117 | 99.1% | |
| STIA007 | 2016 | 107 | 108 | 99.1% | |
| STIA007 | 2017 | 109 | 109 | 100.0% | |
| STIA007 | 2018 | 104 | 105 | 99.0% | |
| STIA007 | 2019 | 105 | 107 | 98.1% | |
| STIA007 | 2020 | 111 | 112 | 99.1% | |
| STIA007 | 2021 | 96 | 112 | 85.7% | |
| STIA007 | 2022 | 95 | 96 | 99.0% | |
| STIA007 | 2023 | 93 | 93 | 100.0% |
